UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey

Fernandes, Georgina; Chappell, Elizabeth; Goetghebuer, Tessa; Kahlert, Christian R; Ansone, Santa; Bernardi, Stefania; Castelli Gattinara, Guido; ... Bamford, Alasdair; + view all (2025) HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey. HIV Medicine , 26 (2) pp. 207-217. 10.1111/hiv.13723. Green open access

[thumbnail of HIV postnatal prophylaxis and infant feeding policies vary across Europe results of a Penta survey.pdf]
Preview
PDF
HIV postnatal prophylaxis and infant feeding policies vary across Europe results of a Penta survey.pdf - Published Version

Download (765kB) | Preview

Abstract

Objectives: This survey was conducted to describe current European postnatal prophylaxis (PNP) and infant feeding policies with the aim of informing future harmonized guidelines. Methods: A total of 32 senior clinicians with relevant expertise, working in 20 countries within the European Region, were invited to complete a REDCap questionnaire between July and September 2023. Results: Twenty-three of the 32 invited paediatricians responded, representing 16/20 countries. There were multiple respondents from the same country for Italy (n = 5), the UK (n = 2), Germany (n = 2) and France (n = 2). All countries use risk stratification to guide PNP regimen selection. Nine out of 16 countries reported three risk categories, six out of 16 reported two, and one country reported differences in categorization. Criteria used to stratify risk varied between and within countries. For the lowest risk category, the PNP regimen reported ranged from no PNP to up to four weeks of one drug; the drug of choice reported was zidovudine, apart from one country which reported nevirapine. For the highest risk category, the most common regimen was zidovudine/lamivudine/nevirapine (20/23 respondents); regimen duration varied from two to six weeks with variation in recommended dosing. Guidelines support breastfeeding for infants born to people living with HIV in eight out of 16 countries; in the other eight, guidelines do not support/specify. Conclusions: Guidelines and practice for PNP and infant feeding vary substantially across Europe and within some countries, reflecting the lack of robust evidence. Effort is needed to align policies and practice to reflect up-to-date knowledge to ensure the vertical transmission risk is minimized and unnecessary infant HIV testing and PNP avoided, while simultaneously supporting families to make informed decisions on infant feeding choice.

Type: Article
Title: HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/hiv.13723
Publisher version: https://doi.org/10.1111/hiv.13723
Language: English
Additional information: © 2024 The Author(s). HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, breastfeeding, HIV, paediatrics, policy, postnatal prophylaxis, vertical transmission, HUMAN-IMMUNODEFICIENCY-VIRUS, TO-CHILD TRANSMISSION, ANTIRETROVIRAL PROPHYLAXIS, BREAST, RISK, PREVENTION, SAFETY, PHARMACOKINETICS, ASSOCIATION, REGIMENS
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10205060
Downloads since deposit
Loading...
3Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item